Lacrimal stents are the thin tubes that are implanted in patients with narrowed but not completely blocked tear ducts. Monocanalicular stents seem to be efficacious and well tolerated in the management of canalicular lacerations. Potential complications include extrusion (most commonly), tube displacement, granuloma, ectropion, slit punctum, fistula, and infection. Bicanalicular stents pass through both the upper and lower canaliculus and typically create a closed circuit. They can intubate the upper and lower canaliculi connecting via the common canaliculus or the lacrimal sac
The lacrimal stent and tube systems market is projected to grow due to increasing incidences and rising geriatric population. Moreover, changing lifestyle and increasing technological advancements in the medical devices industry is expected to propel the growth of the market in the forecast period.
The "Lacrimal Stent and Tube Systems Market Analysis to 2028" is a specialized and in-depth study of the healthcare medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of lacrimal stent and tube systems market with detailed market segmentation by type, and application. The lacrimal stent and tube systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in lacrimal stent and tube systems market and offers key trends and opportunities in the market.
The lacrimal stent and tube systems market is segmented on the basis of type and application. Based on type the market is segmented as monocanalicular stents and bicanalicular stents. On the basis of application, the market is categorized as hospitals, clinics and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the lacrimal stent and tube systems market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lacrimal stent and tube systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting lacrimal stent and tube systems market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lacrimal stent and tube systems market in these regions.
Get more information on this report :
The report covers key developments in the lacrimal stent and tube systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from lacrimal stent and tube systems market are anticipated to have lucrative growth opportunities in the future with the rising demand for lacrimal stent and tube systems in the global market. Below mentioned is the list of few companies engaged in the lacrimal stent and tube systems market.
The report also includes the profiles of key players in lacrimal stent and tube systems market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Bausch + Lomb.
Bess Medizintechnik GmbH
Johnson & Johnson Vision.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.